|1.||Schoub, B D: 4 articles (02/2013 - 02/2005)|
|2.||Department of Health: 4 articles (02/2011 - 02/2005)|
|3.||Chonmaitree, Tasnee: 2 articles (02/2015 - 12/2010)|
|4.||Kremer, Eric J: 2 articles (09/2010 - 02/2004)|
|5.||Hill, Adrian V S: 2 articles (01/2009 - 12/2007)|
|6.||Moore, Anne C: 2 articles (01/2009 - 12/2007)|
|7.||Spaner, David E: 2 articles (02/2006 - 10/2003)|
|8.||Astsaturov, Igor: 2 articles (02/2006 - 10/2003)|
|9.||Iscoe, Neill: 2 articles (02/2006 - 10/2003)|
|10.||Hamilton, Paul: 2 articles (02/2006 - 10/2003)|
07/01/1977 - "This case illustrates the potential hazards of administration of live viral vaccines to an immune compromised host presumed to be in remission and suggests that the continued activity of viral infection may signal the unsuspected persistence of underlying disease."
05/01/2011 - "Collectively, given the demonstrated preclinical immunogenicity and its unique safety profiles, CJ2-gD2 represents a new class of HSV-2 replication-defective recombinant viral vaccines in protection against HSV-2 genital infection and disease."
10/01/2012 - "Modern separation methods, such as capillary electrophoresis, were proposed recently to study viruses and viral infection or to separate and characterize viral vaccines in a time-efficient manner. "
07/07/2008 - "This study motivates efforts to uncover MHC class Ib-restricted CD8 T cell responses in other viral infections, and given the limited polymorphism of MHC class Ib molecules, it raises the possibility of developing peptide-based viral vaccines having broad coverage across MHC haplotypes."
01/01/2014 - "This review explores some of the more prominent recent advances in the biofarming of viral vaccines and therapies, including the recent use of ZMapp for Ebolavirus infection, and explores some possible future applications of the technology. "
01/01/2014 - "In cancer patients, we observed that in vivo infusion with oncolytic vaccinia virus and ex vivo stimulation with viral vaccines promote NK cell activation. "
02/01/2013 - "These features underlie its activity against transplanted tumors and its adjuvanticity in tumor and viral vaccines. "
09/01/2012 - "Recombinant viral vaccines for cancer."
12/01/2011 - "The discovery that certain high-risk strains of human papillomavirus (HR-HPV) cause nearly 100% of invasive cervical cancer has spurred a revolution in cervical cancer prevention by promoting the development of viral vaccines. "
09/01/2010 - "Altogether, viral vaccines could prevent more than 10% of all human tumors. "
10/01/1992 - "Approaches for genetic purity testing of live recombinant viral vaccines using a human adenovirus:rabies model."
10/01/1992 - "A two part purity testing regimen for genetically engineered live viral vaccines is described using a human adenovirus 5: rabies glycoprotein gene recombinant as a model vaccine. "
01/01/1999 - "Recent advances have been made with several inactivated viral vaccines such as equine influenza, where strain variability poses a special problem, or rabies, for which the use of inactivated instead of attenuated vaccines for vaccination of animals became compulsory in many countries."
01/01/1988 - "From the relatively crude or "first generation" vaccines for smallpox, rabies, and yellow fever followed a second and third generation of improved or new viral vaccines. "
01/01/2014 - "In this study, performance of a novel disposable iCELLis fixed bed bioreactor system was investigated for the production of some viral vaccines like Rabies, Hepatitis-A and Chikungunya vaccines in comparison to conventional systems like the commercially available packed bed system and roller bottle system. "
01/01/1990 - "With the exception of the vaccine against hepatitis B the principles involved in the production of the viral vaccines in use today have not changed since Jenner (1) first developed the vaccine which was so important in the control and eventual eradication of smallpox in 1977. "
04/01/1986 - "[Efficacy of domestic hepatitis B viral vaccines in preventing transmission of E antigen from mothers to newborn infants]."
05/01/2009 - "This paper discusses the hypothesis of the 'immune response gene network' and genetic (and bioinformatic) strategies to study associations between immune response gene polymorphisms and variations in humoral and cellular immune responses to prophylactic viral vaccines, such as measles-mumps-rubella, influenza, HIV, hepatitis B and smallpox. "
01/01/1986 - "Results of animal experiments and of field trials using either combined vaccines or simultaneous immunization with diphtheria, tetanus, pertussis, meningococcal and several viral vaccines: polio, rabies, hepatitis-B, etc., will be presented. "
09/01/1986 - "The situation of viral vaccines used in Asian countries is reviewed, focusing on the following vaccines: smallpox, rabies, polio, measles, rubella, mumps, influenza, Japanese encephalitis, hepatitis B, varicella, dengue, and rotavirus. "
|5.||Human Influenza (Influenza)
01/01/2015 - "This approach provides an additional layer of biosafety and thus has great potential for the application in the rational development of safer and more effective influenza viral vaccines. "
03/01/2014 - "Here we provide recommendations for the use of viral vaccines in anticipation of the 2014 southern hemisphere influenza season. "
03/01/2014 - "Recommendations pertaining to the use of viral vaccines: influenza 2014."
02/01/2013 - "Here we provide recommendations for the use of viral vaccines in anticipation of the 2013 Southern Hemisphere influenza season. "
02/01/2013 - "Recommendations pertaining to the use of viral vaccines: influenza 2013."
|4.||Proteins (Proteins, Gene)
|7.||DNA (Deoxyribonucleic Acid)
|8.||Merozoite Surface Protein 1 (MSA1)
|5.||Heterologous Transplantation (Xenotransplantation)